Patrick Geraghty

Professor of Surgery

    • 2083 Citations
    19952020

    Research output per year

    If you made any changes in Pure these will be visible here soon.

    Personal profile

    Research interests

    Dr. Geraghty serves as national or local principal investigator for a number of clinical trials of endovascular intervention, including the VIBRANT trial (percutaneous treatment of leg artery blockages for claudication) and the VIVA-1: XCELL Trial (percutaneous treatment of leg artery blockages for crirical limb ischemia). He is also interested in the design, application, and outcomes of innovative, minimally invasive (endovascular) methods of treating leg artery blockages; the outcomes of endovascular repair of abdominal and thoracic aneurysms; and innovative methods to improve dialysis access.

    Areas of Clinical Interest

    Endovascular (minimally invasive) treatment of aortic aneurysms, aortoiliac occlusive disease, renovascular disease, carotid artery stenosis, lower extremity vascular disease, varicose veins, open surgical treatment for vascular diseases and hemodialysis access, Vein Center Also, aortic dissection, arterial fibrodysplasia, atherosclerosis, Buerger's Disease, claudication, deep venous thrombosis, DVT, diabetic vascular disease, arterial dissection, arterial embolization, fibromuscular dysplasia, FMD, hardening of the arteries, intermittent claudication, intestinal ischemia, mesenteric ischemia, minimally invasive vascular therapy, pediatric vascular care, pediatric vascular surgery, peripheral vascular disease, renal artery disease, renovascular hypertension, thoracic aneurysm, thoracoabdominal aneurysm, thrombolytic therapy, vascular disease, venous insufficiency, interventional arterial procedures, interventional vascular lymphedema, diagnostic, arteriography, interventional arteriography, lymphedema

    Fingerprint Dive into the research topics where Patrick Geraghty is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

    • 5 Similar Profiles

    Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    Corrigendum to ‘Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia’ (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))

    GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS) & European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS), Mar 2020, In : European Journal of Vascular and Endovascular Surgery. 59, 3, p. 492-493 2 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • 1 Scopus citations

    Corrigendum to “Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia” [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1–109>] (European Journal of Vascular & Endovascular Surgery (2019) 58(1S) (S1–S109.e33), (S1078588419303806), (10.1016/j.ejvs.2019.05.006))

    GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS) & World Federation of Vascular Societies (WFVS), Jul 2020, In : European Journal of Vascular and Endovascular Surgery. 60, 1, p. 158-159 2 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • 1 Scopus citations
  • Drug-coated vs uncoated percutaneous transluminal angioplasty in infrapopliteal arteries: Six-month results of the lutonix BTK trial

    Mustapha, J. A., Brodmann, M., Geraghty, P. J., Saab, F., Settlage, R. A. & Jaff, M. R., Jan 1 2019, In : Journal of Invasive Cardiology. 31, 8, p. 205-211 7 p.

    Research output: Contribution to journalArticle

  • 14 Scopus citations